| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |